Page last updated: 2024-11-05

trifluoperazine and Squamous Cell Carcinoma of Head and Neck

trifluoperazine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Körbel, C1
Linxweiler, M1
Bochen, F1
Wemmert, S1
Schick, B1
Meyer, M1
Maurer, H1
Menger, MD1
Zimmermann, R1
Greiner, M1

Other Studies

1 other study available for trifluoperazine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine.
    Biomolecular concepts, 2018, May-19, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Carcinoma, Squamous Cell; Cell

2018